Laboratory Corporation of America Holdings
NYSE:LH
Laboratory Corporation of America Holdings
Total Receivables
Laboratory Corporation of America Holdings
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Receivables
$2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
DaVita Inc
NYSE:DVA
|
Total Receivables
$3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Chemed Corp
NYSE:CHE
|
Total Receivables
$177.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Receivables
$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Total Receivables
$32.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Total Receivables
$20.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Laboratory Corporation of America Holdings's Total Receivables?
Total Receivables
2.2B
USD
Based on the financial report for Mar 31, 2024, Laboratory Corporation of America Holdings's Total Receivables amounts to 2.2B USD.
What is Laboratory Corporation of America Holdings's Total Receivables growth rate?
Total Receivables CAGR 10Y
10%
Over the last year, the Total Receivables growth was -28%. The average annual Total Receivables growth rates for Laboratory Corporation of America Holdings have been -9% over the past three years , 2% over the past five years , and 10% over the past ten years .